Defactinib hydrochloride,
1073160-26-5,
Defactinib (hydrochloride),
Defactinib HCl,
UNII-L2S469LM49,
Defactinib hydrochloride [USAN],
L2S469LM49,
Defactinib hydrochloride (USAN),
Benzamide, N-methyl-4-[[4-[[[3-[methyl(methylsulfonyl)amino]-2-pyrazinyl]methyl]amino]-5-(trifluoromethyl)-2-pyrimidinyl]amino]-, hydrochloride,
Benzamide, N-methyl-4-((4-(((3-(methyl(methylsulfonyl)amino)-2-pyrazinyl)methyl)amino)-5-(trifluoromethyl)-2-pyrimidinyl)amino)-, hydrochloride (1:1),
Benzamide, N-methyl-4-[[4-[[[3-[methyl(methylsulfonyl)amino]-2-pyrazinyl]methyl]amino]-5-(trifluoromethyl)-2-pyrimidinyl]amino]-, hydrochloride (1:1),
SCHEMBL1626017,
PF 04554878 hydrochloride,
PF-04554878 hydrochloride,
CHEMBL3137305,
BCP17737,
EX-A1036,
HY-12289A,
MFCD28144730,
AKOS030526238,
CS-3411,
SB17059,
vs-6063, pf-04554878,
D10619,
DEFACTINIB (VS-6063, PF-04554878)HCL,
Defactinib HCl; (VS-6063, PF-04554878)hydrochloride,
N-Methyl-4-((4-(((3-(methyl(methylsulfonyl)amino)pyrazin-2-yl)methyl)amino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)benzamide monohydrochloride,
N-methyl-4-[[4-[[3-[methyl(methylsulfonyl)amino]pyrazin-2-yl]methylamino]-5-(trifluoromethyl)pyrimidin-2-yl]amino]benzamide;hydrochloride,
VS-6063,
PF-04554878,
1073160-26-5 (HCl),